Price$0.15-0.01 (-8.19%)
03:00 PM07:45 PM
News · 26 weeks40-11%
2026-04-192026-10-11
Mix2790d
- SEC Filings15(56%)
- Insider4(15%)
- Other3(11%)
- Earnings2(7%)
- Leadership2(7%)
- Dividends1(4%)
Latest news
25 items- SECSEC Form DEF 14A filed by Accuray IncorporatedDEF 14A - ACCURAY INC (0001138723) (Filer)
- SECSEC Form 8-K filed by Accuray Incorporated8-K - ACCURAY INC (0001138723) (Filer)
- INSIDERSEC Form 4 filed by Accuray Incorporated4 - ACCURAY INC (0001138723) (Issuer)
- INSIDERSEC Form 3 filed by Accuray Incorporated3 - ACCURAY INC (0001138723) (Issuer)
- PRAccuray Announces Stockholder Approval of Key Financing-Related Proposals and Appointment of New Independent DirectorMADISON, Wis., Oct. 6, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ:ARAY) today announced that stockholders approved all proposals presented at the company's Special Meeting of Stockholders held on October 6, 2026, enabling Accuray to complete its previously announced transactions with TCW Asset Management Company LLC, the company's primary lender and largest shareholder.In July 2026, Accuray announced a comprehensive plan to strengthen its financial position and support long-term value creation, including definitive agreements with TCW Asset Management Company LLC intended to improve the company's balance sheet, provide additional liquidity, and enhance financial flexibility. The trans
- SECSEC Form 8-K filed by Accuray Incorporated8-K - ACCURAY INC (0001138723) (Filer)
- INSIDERSVP Chief Financial Officer Pervaiz Ali was granted 19,811 shares and covered exercise/tax liability with 8,915 shares, increasing direct ownership by 3% to 366,259 units (SEC Form 4) (for tax liability)4 - ACCURAY INC (0001138723) (Issuer)
- PRAccuray and Samsung NeuroLogica Advance Volumetric Imaging Collaboration for the Accuray CyberKnife® PlatformMADISON, Wis., Sept. 27, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ:ARAY) today announced that it had entered into agreements with Samsung HME America, Inc., dba NeuroLogica Corp. ("Samsung NeuroLogica") to pursue advanced volumetric imaging capabilities for the CyberKnife® System. The announcement coincides with the American Society of Radiation Oncology (ASTRO) Annual Meeting in Boston, Massachusetts, where the companies are highlighting their collaboration. The collaboration represents another example of Accuray's strategy to address customer priorities through targeted partnerships that bring together complementary expertise.
- SECSEC Form DEFA14A filed by Accuray IncorporatedDEFA14A - ACCURAY INC (0001138723) (Filer)
- SECSEC Form EFFECT filed by Accuray IncorporatedEFFECT - ACCURAY INC (0001138723) (Filer)
- SECSEC Form 424B3 filed by Accuray Incorporated424B3 - ACCURAY INC (0001138723) (Filer)
- PRAccuray and RaySearch Agree to Collaboration Integrating RayStation Software with Accuray Platforms to Accelerate Accuray's Online Adaptive CapabilitiesMADISON, Wis., Sept. 11, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ:ARAY), a leading provider of radiation therapy systems for cancer treatment, and RaySearch Laboratories AB (publ) today announced that they had entered into a definitive agreement providing for an expanded collaboration aimed at accelerating Accuray's adoption of online adaptive radiation therapy.The collaboration combines Accuray's advanced photon-based radiation therapy platforms and imaging capabilities with RaySearch's treatment planning and workflow software to enable online adaptive radiation therapy. The initial focus is on Accuray's Radixact® and the solution will be extended to the CyberKnife® platform in the
- SECAmendment: SEC Form S-3/A filed by Accuray IncorporatedS-3/A - ACCURAY INC (0001138723) (Filer)
- SECAmendment: SEC Form SCHEDULE 13D/A filed by Accuray IncorporatedSCHEDULE 13D/A - ACCURAY INC (0001138723) (Subject)
- INSIDERSEC Form 4 filed by Large owner Tcw Group Inc4 - ACCURAY INC (0001138723) (Issuer)
- SECSEC Form 10-K filed by Accuray Incorporated10-K - ACCURAY INC (0001138723) (Filer)
- SECSEC Form DEF 14A filed by Accuray IncorporatedDEF 14A - ACCURAY INC (0001138723) (Filer)
- SECAmendment: SEC Form S-3/A filed by Accuray IncorporatedS-3/A - ACCURAY INC (0001138723) (Filer)
- PRAccuray Reports Fourth Quarter and Fiscal 2026 Financial ResultsMADISON, Wis., Aug. 19, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ:ARAY) today reported financial results for the fourth quarter and fiscal 2026, ended June 30, 2026. Key HighlightsThe Company's transformation plan delivered more than $20 million of cost and margin improvement during fiscal 2026, significantly exceeding the Company's original target of $12 million.The Company announced a comprehensive financing transaction with TCW Asset Management that strengthens liquidity, reduces leverage, provides relief for certain covenants through December 2027, and enhances financial flexibility to support long-term strategic ob
- SECAccuray Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - ACCURAY INC (0001138723) (Filer)
- SECSEC Form PRE 14A filed by Accuray IncorporatedPRE 14A - ACCURAY INC (0001138723) (Filer)
- PRAccuray Advances Strategic Priorities Through Key Executive Leadership AppointmentsMADISON, Wis., Aug. 12, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ:ARAY) announced two key leadership appointments intended to improve operational execution and profitability, deliver increased customer value, and enhance overall enterprise performance as the company continues to advance the strategic priorities in its recently announced transformation plan focused on sustainable, profitable growth. As part of these efforts, Accuray has named Todd Brown to lead the company's newly created Enterprise Performance Optimization organization and has appointed Sofiane Laoussadi as Senior Vice President, Global Services & Solut
- SECAccuray Incorporated filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - ACCURAY INC (0001138723) (Filer)
- PRAccuray to Report Fourth Quarter Fiscal 2026 Financial Results on August 19, 2026MADISON, Wis., Aug. 5, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ:ARAY) will report financial results for the fourth quarter of fiscal year 2026, ended June 30, 2026, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on August 19, 2026. The conference call dial-in numbers are 1-833-316-0563 (USA) or 1-412-317-5747 (international). In addition, a dial-up replay of the conference call will be available approximately one hour after the call's conclusion for one week. The replay number is 1-855-669-9658 (USA) or 1-412-317-0088 (international), conference ID: 6917084.A live webcast of the call
- SECSEC Form S-3 filed by Accuray IncorporatedS-3 - ACCURAY INC (0001138723) (Filer)
ARAY FAQ
7 questionsWhat does Accuray Incorporated do?
Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body in the Americas, Europe, the Middle East, India, Japan, Africa, and rest of the Asia Pacific region. The company offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body. Its CyberKnife System automatically tracks, detects, and corrects for tumor and patient movement in real-time during the procedure, as well as enables the delivery of...Where does ARAY stock trade?
Accuray Incorporated (ARAY) is listed on NASDAQ.What sector and industry is ARAY in?
Accuray Incorporated operates in the Health Care sector, Medical/Dental Instruments industry.When did Accuray Incorporated go public?
Accuray Incorporated (ARAY) completed its IPO in 2007.What are analysts saying about ARAY?
Accuray Incorporated has had 4 recent analyst actions on file. The most recent action was from BTIG Research: Neutral on 2026-05-07. Recent price targets range from $750.00 to $900.00.What companies are similar to ARAY?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), BDX (Becton Dickinson and Company), MDLN (Medline Inc.). Compare ARAY side-by-side with any of them on Quantisnow.How can I track ARAY on Quantisnow?
Quantisnow aggregates Accuray Incorporated's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ARAY to receive live email and push alerts on every new disclosure.